Skip to main content

Peer Review reports

From: Combining gene expression analysis of gastric cancer cell lines and tumor specimens to identify biomarkers for anti-HER therapies—the role of HAS2, SHB and HBEGF

Original Submission
14 Aug 2021 Submitted Original manuscript
15 Sep 2021 Reviewed Reviewer Report
2 Oct 2021 Reviewed Reviewer Report
6 Nov 2021 Author responded Author comments - Birgit Luber
Resubmission - Version 2
6 Nov 2021 Submitted Manuscript version 2
10 Nov 2021 Reviewed Reviewer Report
13 Nov 2021 Reviewed Reviewer Report
14 Dec 2021 Author responded Author comments - Birgit Luber
Resubmission - Version 3
14 Dec 2021 Submitted Manuscript version 3
18 Jan 2022 Author responded Author comments - Birgit Luber
Resubmission - Version 4
18 Jan 2022 Submitted Manuscript version 4
28 Jan 2022 Reviewed Reviewer Report
Resubmission - Version 5
Submitted Manuscript version 5
Publishing
24 Feb 2022 Editorially accepted
9 Mar 2022 Article published 10.1186/s12885-022-09335-4

You can find further information about peer review here.

Back to article page